Literature DB >> 7958618

Functions of glutathione and glutathione disulfide in immunology and immunopathology.

W Dröge1, K Schulze-Osthoff, S Mihm, D Galter, H Schenk, H P Eck, S Roth, H Gmünder.   

Abstract

Even a moderate increase in the cellular cysteine supply elevates the intracellular glutathione (GSH) and glutathione disulfide (GSSG) levels and potentiates immunological functions of lymphocytes in vitro. At low GSSG levels, T cells cannot optimally activate the immunologically important transcription factor NF kappa B, whereas high GSSG levels inhibit the DNA binding activity of NF kappa B. The effects of GSSG are antagonized by reduced thioredoxin (TRX). As the protein tyrosine kinase activities p56lck and p59fyn are activated in intact cells by hydrogen peroxide, they are likely targets for GSSG action. These redox-regulated enzymes trigger signal cascades for NF kappa B activation and transduce signals from the T cell antigen receptor, from CD4 and CD8 molecules, and from the IL-2 receptor beta-chain. The effector phase of cytotoxic T cell responses and IL-2-dependent functions are inhibited even by a partial depletion of the intracellular GSH pool. As signal transduction is facilitated by prooxidant conditions, we propose that the well-known immunological consequences of GSH depletion ultimately may be results of the accompanying GSSG deficiency. As HIV-infected patients and SIV-infected rhesus macaques have, on the average, significantly decreased plasma cyst(e)ine and intracellular GSH levels, we also hypothesize that AIDS may be the consequence of a GSSG deficiency as well.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958618

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  54 in total

Review 1.  Redox platforms in cancer drug discovery and development.

Authors:  Kenneth D Tew; Danyelle M Townsend
Journal:  Curr Opin Chem Biol       Date:  2010-11-11       Impact factor: 8.822

2.  Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis.

Authors:  J J Haddad; S C Land
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Oxidative stress-induced disruption of epithelial and endothelial tight junctions.

Authors:  Radhakrishna Rao
Journal:  Front Biosci       Date:  2008-05-01

Review 4.  Role of transcription factors in inflammatory lung diseases.

Authors:  I Rahman; W MacNee
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

5.  Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice.

Authors:  H Hentze; F Gantner; S A Kolb; A Wendel
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

6.  Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.

Authors:  Kyle E Giesler; Jose Marengo; Dennis C Liotta
Journal:  J Med Chem       Date:  2016-07-22       Impact factor: 7.446

7.  Selective regulation of CD40 expression in murine dendritic cells by thiol antioxidants.

Authors:  Norifumi Iijima; Yoshiki Yanagawa; Kazuya Iwabuchi; Kazunori Onoé
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  HIV-induced changes in T cell signaling pathways.

Authors:  Marc Schweneker; David Favre; Jeffrey N Martin; Steven G Deeks; Joseph M McCune
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

9.  Age associated oxidative damage in lymphocytes.

Authors:  Nandeslu Gautam; Subhasis Das; Santanu Kar Mahapatra; Subhankari Prasad Chakraborty; Pratip Kumar Kundu; Somenath Roy
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

10.  HIV infection--induced posttranslational modification of T cell signaling molecules associated with disease progression.

Authors:  I Stefanová; M W Saville; C Peters; F R Cleghorn; D Schwartz; D J Venzon; K J Weinhold; N Jack; C Bartholomew; W A Blattner; R Yarchoan; J B Bolen; I D Horak
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.